Advertisement
ProteinSimple
ProteinSimple

Fish Hurt by Drug Waste

Waste from pharmaceutical factories is finding its way to the world’s waterways, and affecting the sexual attributes of local fish.

By | August 16, 2011

WIKIMEDIA COMMONS, MARK ASHMANN

A series of recent studies suggests that pharmaceutical factories are not as careful with their waste as they should be, Nature reports. First, a 2009 study found high levels of bioactive ingredients in treated waste being released from a wastewater-treatment plant in India. Last year, investigations of two water-processing plants in New York revealed similar events. And now, new evidence published in Environment International suggests bioactive drugs are also making it into the waterways in France, and that they are affecting the fish populations in the local rivers.

Specifically, the new study, commissioned by the French environment ministry after the sighting of some abnormal fish, examined wild gudgeons (Gobio gobio) in a river near a Sanofi-owned facility that manufactures steroid compounds. The researchers found that downstream of the factory’s discharge, the gudgeons were largely “intersex,” with as many as 80 percent of fish containing both male and female sexual characteristics, whereas upstream of the factory, only 5 percent of the fish showed these abnormal qualities.

Testing the water, the researchers found high concentrations of an anti-inflammatory and immunosuppressant called dexamethasone, a diuretic called spironolactone, which is known to block the effects of male sex hormones, and another diuretic called canrenone. "This is a real problem," Wilfried Sanchez, an ecotoxicologist at the French National Institute for Industrial Environment and Risks, and lead author of the study, told Nature, noting that such abnormalities may affect the fish’s ability to breed, and could have subsequent consequences for the entire river ecosystem.

The findings are raising the issue of oversight regarding the disposal of bioactive chemicals. According to Nature, the United States, the European Union, the United Kingdom and France all have no regulations “limiting the concentrations of pharmaceuticals released into the aquatic environment in either municipal wastewater or in effluent from manufacturing facilities.” The European Commission is now considering placing such limits for certain drugs that have turned up in rivers and streams around pharmaceutical plants, and is expected to announce its decision later this year.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: SciFi-or-SciTru

Anonymous

August 17, 2011

In all honesty, I am much more worried about the huddled masses throwing their drugs away down the sink than I ever will be from a drug company waste pipe.  Many municipalities are having to use very expensive and sophisticated means to remove "drugs" from our drinking water because I throw away a bottle of aspirin that is 5 years past the expiration date.....

Avatar of:

Posts: 0

August 17, 2011

In all honesty, I am much more worried about the huddled masses throwing their drugs away down the sink than I ever will be from a drug company waste pipe.  Many municipalities are having to use very expensive and sophisticated means to remove "drugs" from our drinking water because I throw away a bottle of aspirin that is 5 years past the expiration date.....

Avatar of:

Posts: 0

August 17, 2011

In all honesty, I am much more worried about the huddled masses throwing their drugs away down the sink than I ever will be from a drug company waste pipe.  Many municipalities are having to use very expensive and sophisticated means to remove "drugs" from our drinking water because I throw away a bottle of aspirin that is 5 years past the expiration date.....

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
INTEGRA
INTEGRA
Advertisement
Life Technologies